Sexcord/ stromal ovarian tumors risk factors: Difference between revisions
| Line 19: | Line 19: | ||
==Risk Factors== | ==Risk Factors== | ||
The risk factors for the development of sexcord-stromal ovarian tumors are as follows:<ref name="pmid24530563">{{cite journal |vauthors=Sieh W, Sundquist K, Sundquist J, Winkleby MA, Crump C |title=Intrauterine factors and risk of nonepithelial ovarian cancers |journal=Gynecol. Oncol. |volume=133 |issue=2 |pages=293–7 |date=May 2014 |pmid=24530563 |pmc=4006291 |doi=10.1016/j.ygyno.2014.02.007 |url=}}</ref> | The risk factors for the development of sexcord-stromal ovarian tumors are as follows:<ref name="pmid24530563">{{cite journal |vauthors=Sieh W, Sundquist K, Sundquist J, Winkleby MA, Crump C |title=Intrauterine factors and risk of nonepithelial ovarian cancers |journal=Gynecol. Oncol. |volume=133 |issue=2 |pages=293–7 |date=May 2014 |pmid=24530563 |pmc=4006291 |doi=10.1016/j.ygyno.2014.02.007 |url=}}</ref><ref name="pmid21177423">{{cite journal |vauthors=Chen T, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H, Kaaks R, Koskela P, Grankvist K, Hallmans G, Pukkala E, Zeleniuch-Jacquotte A, Toniolo P, Lehtinen M, Lukanova A |title=Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer |journal=Cancer Epidemiol. Biomarkers Prev. |volume=20 |issue=2 |pages=324–36 |date=February 2011 |pmid=21177423 |pmc=3082204 |doi=10.1158/1055-9965.EPI-10-0857 |url=}}</ref> | ||
*Preterm birth is a risk factor for developing sex cord-stromal tumors | *Preterm birth is a risk factor for developing sex cord-stromal tumors | ||
*High gonadotropin levels in preterm girls could mediate disease risk by the proliferative and steroidogenic effects of FSH and LH on granulosa and theca cells | *High gonadotropin levels in preterm girls could mediate disease risk by the proliferative and steroidogenic effects of FSH and LH on granulosa and theca cells | ||
Revision as of 19:08, 28 March 2019
|
Sexcord/ stromal ovarian tumors Microchapters |
|
Differentiating Sexcord/ Stromal Ovarian Tumors from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Sexcord/ stromal ovarian tumors risk factors On the Web |
|
American Roentgen Ray Society Images of Sexcord/ stromal ovarian tumors risk factors |
|
Risk calculators and risk factors for Sexcord/ stromal ovarian tumors risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no established risk factors for [disease name].
OR
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
Risk Factors
The risk factors for the development of sexcord-stromal ovarian tumors are as follows:[1][2]
- Preterm birth is a risk factor for developing sex cord-stromal tumors
- High gonadotropin levels in preterm girls could mediate disease risk by the proliferative and steroidogenic effects of FSH and LH on granulosa and theca cells
- High circulating levels of androgens during pregnancy were associated with increased risk of maternal sex-cord stromal tumors( indicating that elevated androgens may also play a role in the pathogenesis of sex-cord stromal tumors)
References
- ↑ Sieh W, Sundquist K, Sundquist J, Winkleby MA, Crump C (May 2014). "Intrauterine factors and risk of nonepithelial ovarian cancers". Gynecol. Oncol. 133 (2): 293–7. doi:10.1016/j.ygyno.2014.02.007. PMC 4006291. PMID 24530563.
- ↑ Chen T, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H, Kaaks R, Koskela P, Grankvist K, Hallmans G, Pukkala E, Zeleniuch-Jacquotte A, Toniolo P, Lehtinen M, Lukanova A (February 2011). "Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer". Cancer Epidemiol. Biomarkers Prev. 20 (2): 324–36. doi:10.1158/1055-9965.EPI-10-0857. PMC 3082204. PMID 21177423.